MARC record from Internet Archive

LEADER: 02402cam 2200625 4500
001 ocm01009352
003 OCoLC
005 20191223043849.0
008 740805s1974 ohua b 101 0 eng
010 $a 74011693
040 $aDLC$beng$cDLC$dAGL$dNLM$dOCL$dOCLCQ$dMUQ$dOCLCQ$dBTCTA$dCUI$dBDX$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCL$dOCLCO$dEUW$dOCLCO$dOCLCQ$dOCLCO
016 7 $a7500773$2DNLM
020 $a0878190589
020 $a9780878190584
020 $a0849350859
020 $a9780849350856
035 $a(OCoLC)1009352
050 00 $aRS189$b.C6122 1973
050 14 $aRC268.5$b.C6122 1973
060 00 $aQZ 202$bC7472 1973
070 0 $aRS189.C6122$b1973
072 0 $aX380
082 00 $a614.3/5
111 2 $aConference on Carcinogenesis Testing in the Development of New Drugs$d(1973 :$cWashington, D.C.)
245 10 $aCarcinogenesis testing of chemicals;$bproceedings.$ceditor, Leon Golberg.
260 $aCleveland,$bCRC Press$c[1974]
300 $a144 pages$billustrations$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references.
650 0 $aDrugs$xTesting$vCongresses.
650 0 $aChemicals$xPhysiological effect$vCongresses.
650 0 $aCarcinogenesis$vCongresses.
650 6 $aMe dicaments$xEssais$xCongre s.
650 6 $aProduits chimiques$xEffets physiologiques$xCongre s.
650 6 $aCance rogene se$vCongre s.
650 7 $aCarcinogenesis.$2fast$0(OCoLC)fst00846974
650 7 $aChemicals$xPhysiological effect.$2fast$0(OCoLC)fst00853299
650 7 $aDrugs$xTesting.$2fast$0(OCoLC)fst00898940
650 2 $aCarcinogens.$0https://id.nlm.nih.gov/mesh/D002273
650 2 $aDrug Evaluation.$0https://id.nlm.nih.gov/mesh/D004341
650 2 $aDrug Evaluation, Preclinical.$0https://id.nlm.nih.gov/mesh/D004353
655 4 $aConference proceedings.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aGolberg, Leon,$eeditor.
938 $aBrodart$bBROD$n26538539$c$44.95
938 $aBaker and Taylor$bBTCP$n74011693
029 1 $aAU@$b000000443433
029 1 $aGBVCP$b197151728
029 1 $aNLM$b7500773
029 1 $aNZ1$b3259418
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 265 OTHER HOLDINGS